
U.S. Drug Enforcement Administration chief Anne Milgram speaks throughout a information convention in April. On Friday, the DEA introduced it is going to strip one of many nation’s largest drug distributors of its license to promote extremely addictive painkillers after figuring out it did not flag hundreds of suspicious orders on the peak of the opioid disaster.
Susan Walsh/AP
cover caption
toggle caption
Susan Walsh/AP

U.S. Drug Enforcement Administration chief Anne Milgram speaks throughout a information convention in April. On Friday, the DEA introduced it is going to strip one of many nation’s largest drug distributors of its license to promote extremely addictive painkillers after figuring out it did not flag hundreds of suspicious orders on the peak of the opioid disaster.
Susan Walsh/AP
The U.S. Drug Enforcement Administration says it is going to strip one of many nation’s largest drug distributors of its license to promote and ship extremely addictive painkillers inside 90 days if some type of negotiated settlement is not reached.
In an announcement, DEA Administrator Anne Milgram stated executives at Morris & Dickson failed to just accept accountability for the “full extent of their wrongdoing … and the potential hurt it brought on.”
If finalized, this motion taken Friday would hobble the nation’s fourth-largest drug wholesaler. It comes after a controversial four-year delay.
In an announcement despatched to NPR, the Louisiana-based firm stated it stays in talks with the DEA as a part of a last-ditch try and avert the revocation of its opioid license.
“Morris & Dickson is grateful to the DEA Administrator for delaying the efficient date of the order to permit time to settle these previous points, which has been our objective since this began years in the past,” the assertion stated.
The corporate faces accusations it shipped extremely addictive opioid ache tablets for years regardless of proof the medicine had been being misused.
Deadly overdoses from prescription ache tablets nonetheless kill greater than 15,000 People a 12 months. Public well being specialists say prescription opioid abuse opened the U.S. to an much more lethal disaster involving heroin and fentanyl.
Friday’s motion has been lengthy awaited. In 2019, a federal decide really helpful the DEA revoke Morris & Dickson’s opioid license due to the corporate’s “cavalier disregard” for security guidelines.
In a 68-page order issued Friday, the DEA acknowledged its resolution to revoke the corporate’s opioid license took “longer than typical for the company.”
Federal officers blamed the pandemic and actions by the corporate for delays.
An investigation by The Related Press additionally discovered {that a} high DEA official, Louis Milione, served beforehand as a marketing consultant for Morris & Dickson as a part of the corporate’s effort to keep away from punishment. The DEA says after Milione took his authorities put up in 2021, he recused himself any function within the Morris & Dickson matter.
U.S. regulatory companies, together with the DEA, have confronted criticism in recent times for failing to crack down on companies that manufactured, distributed or offered opioid ache tablets.
Different drug distributors concerned within the opioid disaster have been allowed to proceed delivery ache tablets however agreed to tighter oversight and pays greater than $21 billion in settlements over the following 18 years.
In its assertion, Morris and Dickson stated it has additionally revamped its “compliance methods and processes” in an effort to enhance security.